Argenica Therapeutics Limited (AGN.AX)
AUD 0.64
(-2.29%)
AUD 0.64
(-2.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -5.47 Million AUD | -13.8% |
| 2023 | -4.81 Million AUD | -17.71% |
| 2022 | -4.09 Million AUD | -297.35% |
| 2021 | -1.02 Million AUD | -168.52% |
| 2020 | -383.4 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -2.03 Million AUD | -44.37% |
| 2024 Q4 | -2.03 Million AUD | 0.0% |
| 2024 FY | -5.47 Million AUD | -13.8% |
| 2024 Q2 | -1.4 Million AUD | -100.0% |
| 2024 Q1 | -704.77 Thousand AUD | 78.4% |
| 2023 Q2 | -1.55 Million AUD | -100.0% |
| 2023 FY | -4.81 Million AUD | -17.71% |
| 2023 Q4 | -3.26 Million AUD | -100.0% |
| 2023 Q3 | -1.63 Million AUD | -5.15% |
| 2023 Q1 | -775.87 Thousand AUD | 66.92% |
| 2022 FY | -4.09 Million AUD | -297.35% |
| 2022 Q3 | -1.17 Million AUD | 32.81% |
| 2022 Q2 | -1.74 Million AUD | -100.0% |
| 2022 Q1 | -872.7 Thousand AUD | 20.28% |
| 2022 Q4 | -2.34 Million AUD | -100.0% |
| 2021 FY | -1.02 Million AUD | -168.52% |
| 2021 Q2 | 65.24 Thousand AUD | 99.99% |
| 2021 Q4 | -1.09 Million AUD | -100.0% |
| 2021 Q1 | 32.62 Thousand AUD | 108.51% |
| 2021 Q3 | -547.37 Thousand AUD | -938.99% |
| 2020 Q2 | -200.00 AUD | 0.0% |
| 2020 FY | -383.4 Thousand AUD | 0.0% |
| 2020 Q4 | -383.2 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -1.825% |
| Acrux Limited | -5.8 Million AUD | 5.526% |
| Actinogen Medical Limited | -13.04 Million AUD | 57.993% |
| AnteoTech Limited | -8.88 Million AUD | 38.298% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 37.349% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -277.572% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 71.347% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -21.673% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -59.447% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -127.442% |
| Biome Australia Limited | -1.67 Million AUD | -228.073% |
| Biotron Limited | -3.43 Million AUD | -59.449% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 60.493% |
| BTC Health Limited | 1.05 Million AUD | 619.241% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 56.269% |
| CSL Limited | 2.64 Billion AUD | 100.207% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 87.054% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 115.376% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 43.77% |
| Dimerix Limited | -17.07 Million AUD | 67.909% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 178.678% |
| Hexima Limited | -933.87 Thousand AUD | -486.749% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -91.302% |
| Immuron Limited | -6.93 Million AUD | 21.01% |
| Immutep Limited | -39.89 Million AUD | 86.266% |
| Imugene Limited | -149.68 Million AUD | 96.339% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -233.747% |
| Memphasys Limited | -4.44 Million AUD | -23.356% |
| Nanollose Limited | -1.15 Million AUD | -373.778% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 103.488% |
| Noxopharm Limited | -3.57 Million AUD | -53.139% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 1790.105% |
| Nyrada Inc. | -1.38 Million AUD | -295.281% |
| Orthocell Limited | -7.18 Million AUD | 23.694% |
| PharmAust Limited | -9.03 Million AUD | 39.335% |
| Patrys Limited | -3.53 Million AUD | -54.825% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 90.658% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 14.064% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 33.486% |
| PYC Therapeutics Limited | -37.72 Million AUD | 85.475% |
| Race Oncology Limited | -13.81 Million AUD | 60.349% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 88.572% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 68.975% |
| Starpharma Holdings Limited | -8.16 Million AUD | 32.891% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 205.152% |
| Tissue Repair Ltd | -4.13 Million AUD | -32.415% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 85.016% |